Abstract:Objective To assess the protective effect of vaccination in routine application on hepatitis B virus (HBV) exposed infants and to clarify whether hepatitis B immunoglobulin (HBIG) administration of pregnant women may reduce the risk of maternal-fetal transmission of HBV. Methods Serum samples of 6398 pregnant women at gestation of 15-20 weeks from 6 urban and 8 rural areas across Jiangsu province were previously tested for serologic markers of HBV by ELISA from July 2002 to August 2004. In this study, infants born to 419 HBV carrier mothers were taken as the study group, while infants born to 453 non-carrier mothers were taken as the control group by stratified random sampling. They were followed-up and screened for HBV markers during October 2009 to March 2010. Information including HBIG administration during pregnancy, HBV vaccination and HBIG administration of the infants were collected. χ2 test or Fisher′s exact method were used to compare the rates and the comparison of the means was by t test. Results The follow-up rates of the study group and control group were 71.12% (298/419) and 72.41% (328/453), respectively. Of the 298 infants born to HBV carrier mothers, 11 (3.7%) were positive for HBsAg, while none of the 328 infants born to non-carrier mothers was HBsAg positive (χ2=12.32, P<0.01). All of the 11 children were born to mothers with both HBsAg and HBeAg positive, and nine of the 11 children were not injected HBIG or not immunized with hepatitis B vaccine within 24 hours after birth, with only one received regular vaccination and detailed information was unknown in one case. The positive rates of anti-HBs in the study group and the control group were 69.46% and 69.21% respectively (χ2=0.01, P=0.95). HBsAg positive rate of the children born to pregnant women treated with HBIG during late pregnancy (n=92) was 2.17% (n=2), whereas that in the children born to women not treated with HBIG (n=197) was 4.57% (χ2=0.98, P=0.51). Conclusions The protective effect of immunoprophylaxis in routine application against perinatal HBV infection in Jiangsu province is good. Efforts are required to emphasize the importance of HBIG administration in infants born to HBV carrier mothers, especially in HBeAg positive mothers within 24 hours after delivery. Treatment of HBsAg positive pregnant women with HBIG in third trimester would not decrease the risk of maternal-fetal transmission of HBV.

Transplacentally Acquired Antibodies Against Hepatitis B Surface Antigen in Full Term Infants

Transformation of Hepatitis B Serologic Markers in Babies Born to Hepatitis B Surface Antigen Positive Mothers

Inhibition of Maternal Antibody to Hepatitis B Surface Antigen on Antibody Response to Hepatitis B Vaccine in Infants

Transplacentally Acquired Maternal Antibody Against Hepatitis B Surface Antigen in Infants and Its Influence on the Response to Hepatitis B Vaccine.

The dynamic changes in serologic HBV markers in infants born by HBsAg-carrying mothers

Follow-up study on relationship between hepatitis B e antigens and intrauterine HBV infection after immunoprophylaxis

Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates

Survey of HBsAg-positive Pregnant Women and Their Infants Regarding Measures to Prevent Maternal-Infantile Transmission

Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies.

Influence of maternal antibody against hepatitis B surface antigen on active immune response to hepatitis B vaccine in infants.

No response to hepatitis B vaccine in infants born to HBsAg(+) mothers is associated to the transplacental transfer of HBsAg

Maternal Anti-Hbvs Suppress the Immune Response of Infants to Hepatitis B Vaccine

Results of mother-to-child transmission in hepatitis B-positive mothers who underwent amniocentesis

Mother‐to‐infant Transmission of Hepatitis B Virus: A Chinese Experience

Protective effect of regular immunoprophylaxis on infants against perinatal hepatitis B virus infection

Study on Preventive Effect of Materneofetal Hepatitis B Virus Transmission

Study of the relationship in pregnant women between hepatitis B markers and a placenta positive for hepatitis B surface antigen

Epidemiological trends and virological traits of hepatitis B virus infection in pregnant women and neonates

Quantitative Hepatitis B Surface Antigen Predicts Hepatitis B Transmission in Infants Born to e Antigen-positive Mothers.

Effect of neonatal immunoprophylaxis in mother-to-fetus transmission of HBV and analysis on risk factors for transmission

Evaluation for Effects of Routine Administration of Hepatitis B Vaccine and Hepatitis B Immunoglobulin on Preventing Mother-to-Infant Transmission of HBV-infected Mothers with Negative HBeAg